SENOTHERAPEUTIX, Inc. Press Releases

• Published on September 5, 2025 - 18:00 GMT

  

  MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies

  • Agreement focuses on rimiducid, an agent used to activate certain "safety switch" cell elimination technologies in cell and gene therapies HOUSTON, TX, UNITED STATES, September 5, 2025 /⁨EINPresswire.com⁩/ -- • Phoenix receives a …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...
• Published on September 4, 2025 - 10:00 GMT

  

  PrintBio Introduces DynaFlex™ Programmable Surgical Mesh (PSM) at American Hernia Society Meeting 2025

  • DynaFlex™ Incorporates MetaDirectional Flex™ Technology to Create the First-of-Its-Kind Programmable Mesh LONG ISLAND CITY, NY, UNITED STATES, September 4, 2025 /⁨EINPresswire.com⁩/ -- PrintBio today announced commencement of its phased commercial …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on September 3, 2025 - 20:25 GMT

  

  PrintBio Reorganizes and Expands Leadership Team with Key Commercial and Market Development Appointments

  • Launches Hernia Division to Focus on Abdominal Wall Repair Solutions • Strengthens Leadership to Drive Market Readiness for Surgical Innovation LONG ISLAND CITY, NY, UNITED STATES, September 3, 2025 /⁨EINPresswire.com⁩/ -- PrintBio announced today the …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on May 27, 2025 - 12:00 GMT

  

  PrintBio Receives FDA Clearance for 3DMatrix DynaFlex™, Adding Uniflex™ Technology to its First Product, 3DMatrix™

  3DMatrix DynaFlex™ incorporates PrintBio’s proprietary Uniflex™ unidirectional flexible mesh technology MIAMI BEACH, FL, UNITED STATES, May 27, 2025 /⁨EINPresswire.com⁩/ -- PrintBio, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) …

  Distribution channels: Banking, Finance & Investment Industry, Beauty & Hair Care ...
• Published on February 26, 2025 - 15:00 GMT

  

  Eos SENOLYTIX, a Longevity Medicine Company, Announces the Appointment of Brent Saunders as Advisory Board Chairman

  • Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 MIAMI, FL, UNITED STATES, February 26, 2025 /⁨EINPresswire.com⁩/ -- Eos SENOLYTIX, Inc., a company …

  Distribution channels: Banking, Finance & Investment Industry, Beauty & Hair Care ...